Headquartered in Pleasanton, California, Roche Molecular Diagnostics (RMD) develops, manufactures and supplies a wide array of innovative medical diagnostic products, tests, platforms and technologies.
RMD employs around 1,400 people across five locations: Pleasanton, California; Branchburg, New Jersey; Los Gatos, Californa; Marlborough, Massachusetts; and Rotkreuz, Switzerland.
With its broad portfolio of oncology, virology, microbiology and blood screening tests, RMD’s clients include researchers, physicians, patients, hospitals, laboratories and blood banks around the world.
The business was founded in the early 1990s following the acquisition of the revolutionary, Nobel-prize winning Polymerase Chain Reaction Technology (PCR). PCR quickly replicates a single specific fragment of DNA or RNA to quantities sufficient for accurate laboratory analysis.